PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30733293-5	2019	The cannabinoid Delta9-tetrahydrocannabinol (THC) disrupts HER2-CB2R complexes by selectively binding to CB2R, which leads to (i) the inactivation of HER2 through disruption of HER2-HER2 homodimers, and (ii) the subsequent degradation of HER2 by the proteasome via the E3 ligase c-CBL.	Cannabinoids	4-15	Cbl proto-oncogene	Homo sapiens	279-284	
28286577-0	2017	In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201).	Cannabinoids	57-68	Cbl proto-oncogene	Homo sapiens	78-81	
28286577-1	2017	In 2014, NM-2201 (CBL-2201), a novel synthetic cannabinoid (SC), was detected by Russian and United States laboratories.	Cannabinoids	47-58	Cbl proto-oncogene	Homo sapiens	18-21